Advancing Diabetes Care: The Future of Continuous Glucose Monitoring in the Management of Diabetes : Episode 5

Opinion

Video

March 21, 2025

Understanding CGM Metrics

Author(s):

Davida Kruger, MSN, APN-BC, BC-ADM ,Jaime Murillo, MD, FACC, FASE

Experts discuss the relative value of different continuous glucose monitoring (CGM) metrics (glucose management indicator [GMI], time in range, glucose variability) in assessing glycemic control and how these outcomes vary across different patient populations.

EP: 1.CGM: Redefining Type 2 Diabetes Management

EP: 2.Key Benefits of CGM Technology

EP: 3.CGM's Impact on Clinical Inertia

EP: 4.CGM vs Traditional Monitoring

EP: 5.Understanding CGM Metrics

EP: 6.Health Care System Integration

EP: 7.CGM Coverage and Access

EP: 8.Implementation Barriers

EP: 9.Overcoming Access Challenges

EP: 10.Adoption Strategies

EP: 11.The Metro Nashville Public Schools Initiative

EP: 12.Health Care Quality Impact

EP: 13.Population Outcomes and Return on Value With CGMs

EP: 14.Long-Term Outcomes Assessment

EP: 15.Closing Perspectives

Video content above is prompted by the following:

Please discuss the relative value of different CGM metrics (GMI, Ttime in Rrange, glucose variability) in assessing glycemic control.

How do these outcomes vary across different patient populations?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions